Nitta Gelatin India Ltd
Nitta Gelatin India Ltd is primarily engaged in the manufacture and sale of ossein, gelatin and collagen peptide.[1]
- Market Cap ₹ 842 Cr.
- Current Price ₹ 927
- High / Low ₹ 1,184 / 697
- Stock P/E 9.95
- Book Value ₹ 341
- Dividend Yield 0.79 %
- ROCE 33.1 %
- ROE 29.2 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 72.7% CAGR over last 5 years
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
244 | 303 | 287 | 354 | 357 | 356 | 342 | 303 | 342 | 396 | 506 | 565 | 548 | |
223 | 260 | 271 | 330 | 321 | 320 | 313 | 273 | 306 | 351 | 442 | 452 | 419 | |
Operating Profit | 21 | 43 | 16 | 24 | 36 | 36 | 29 | 30 | 36 | 45 | 64 | 114 | 129 |
OPM % | 9% | 14% | 5% | 7% | 10% | 10% | 8% | 10% | 10% | 11% | 13% | 20% | 24% |
1 | 2 | 0 | 2 | 2 | 9 | 5 | 1 | 2 | 1 | 5 | 4 | 6 | |
Interest | 6 | 9 | 8 | 10 | 8 | 7 | 7 | 9 | 8 | 6 | 5 | 4 | 1 |
Depreciation | 10 | 16 | 17 | 14 | 13 | 14 | 15 | 15 | 16 | 16 | 14 | 14 | 15 |
Profit before tax | 6 | 20 | -9 | 1 | 18 | 24 | 12 | 7 | 13 | 25 | 49 | 99 | 120 |
Tax % | 24% | 55% | 23% | 358% | 53% | 49% | 61% | 33% | 8% | 29% | 29% | 25% | |
5 | 11 | -7 | -4 | 9 | 12 | 5 | 5 | 12 | 18 | 35 | 74 | 87 | |
EPS in Rs | 4.19 | 9.59 | -6.71 | -1.56 | 11.82 | 15.61 | 4.90 | 3.82 | 12.38 | 19.15 | 36.26 | 77.44 | 93.49 |
Dividend Payout % | 72% | 31% | 0% | -64% | 21% | 16% | 51% | 39% | 20% | 16% | 11% | 10% |
Compounded Sales Growth | |
---|---|
10 Years: | 6% |
5 Years: | 11% |
3 Years: | 18% |
TTM: | -2% |
Compounded Profit Growth | |
---|---|
10 Years: | 20% |
5 Years: | 73% |
3 Years: | 82% |
TTM: | 32% |
Stock Price CAGR | |
---|---|
10 Years: | 24% |
5 Years: | 50% |
3 Years: | 80% |
1 Year: | 12% |
Return on Equity | |
---|---|
10 Years: | 10% |
5 Years: | 15% |
3 Years: | 20% |
Last Year: | 29% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
Reserves | 96 | 105 | 100 | 99 | 105 | 124 | 139 | 141 | 144 | 164 | 192 | 259 | 301 |
Preference Capital | 0 | 0 | 0 | 0 | 16 | 0 | 0 | 0 | 0 | 0 | 4 | 4 | |
60 | 57 | 68 | 66 | 76 | 109 | 104 | 108 | 84 | 80 | 82 | 35 | 21 | |
41 | 52 | 49 | 49 | 65 | 59 | 54 | 55 | 57 | 53 | 62 | 64 | 65 | |
Total Liabilities | 205 | 222 | 226 | 223 | 256 | 301 | 306 | 313 | 294 | 306 | 345 | 367 | 396 |
122 | 117 | 125 | 118 | 120 | 110 | 113 | 130 | 121 | 113 | 107 | 114 | 114 | |
CWIP | 7 | 9 | 9 | 9 | 9 | 13 | 10 | 4 | 4 | 2 | 7 | 7 | 8 |
Investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
75 | 96 | 92 | 96 | 127 | 177 | 182 | 179 | 169 | 191 | 230 | 246 | 272 | |
Total Assets | 205 | 222 | 226 | 223 | 256 | 301 | 306 | 313 | 294 | 306 | 345 | 367 | 396 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
20 | 17 | 24 | 20 | 20 | 11 | 27 | 22 | 40 | 19 | 17 | 101 | |
-20 | -13 | -24 | -8 | -14 | -3 | -7 | -14 | -10 | -7 | -14 | -18 | |
0 | -3 | 0 | -12 | 18 | -5 | -20 | -7 | -33 | -12 | -2 | -55 | |
Net Cash Flow | 0 | 1 | -1 | 0 | 25 | 3 | -0 | 1 | -3 | -0 | 1 | 28 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 26 | 31 | 28 | 23 | 21 | 54 | 66 | 76 | 37 | 58 | 64 | 57 |
Inventory Days | 121 | 140 | 131 | 100 | 114 | 144 | 153 | 191 | 205 | 161 | 136 | 126 |
Days Payable | 62 | 58 | 72 | 51 | 42 | 48 | 53 | 59 | 49 | 43 | 28 | 39 |
Cash Conversion Cycle | 84 | 113 | 87 | 72 | 93 | 150 | 165 | 209 | 193 | 176 | 172 | 144 |
Working Capital Days | 55 | 66 | 62 | 54 | 58 | 97 | 94 | 108 | 78 | 107 | 113 | 90 |
ROCE % | 8% | 17% | -0% | 6% | 13% | 14% | 7% | 6% | 9% | 12% | 20% | 33% |
Documents
Announcements
- Announcement Under Regulation 30(LODR) Regulations -Updates- Bamni Proteins Limited(Subsidiary Company) -Imposition Of Penalty By CGWB 16 Apr
- Compliances- Confirmation Certificate Pursuant To Regulation 40(9) Of SEBI (LODR) Regulations, 2015 11 Apr
-
Compliances- Compliance Certificate For The Period Ended 31St March 2024
11 Apr - All the activities relating to the share transfer facility of the Company are maintained by them.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
11 Apr - Confirmation Certificate received from our Registrar and Share Transfer Agent (RTA), M/s. Cameo Corporate Services Limited, Chennai under Regulation 74(5) of the SEBI (Depositories and …
- Announcement Under Regulation 30 Of SEBI (LODR) Regulations- Updates- Clarification On Price Movement 9 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Product Portfolio
The company's product portfolio includes wellnex collagen peptides, gelatin, Di calcium phosphate, chitosan, and a few consumer products. [1] The products are used for pharmaceutical, agricultural, industrial, and food applications. [2]